Page last updated: 2024-08-24

gemcitabine and Leukemia, Prolymphocytic

gemcitabine has been researched along with Leukemia, Prolymphocytic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Nguyen, NP; Sallah, S; Wan, JY	1

Trials

1 trial(s) available for gemcitabine and Leukemia, Prolymphocytic

Article	Year
Treatment of refractory T-cell malignancies using gemcitabine. British journal of haematology, 2001, Volume: 113, Issue:1 Topics: Aged; Antimetabolites, Antineoplastic; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Humans; Infusions, Intravenous; Leukemia, Prolymphocytic; Lymphoma, T-Cell; Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Recurrence; Salvage Therapy; Treatment Outcome	2001

Article

Year

Treatment of refractory T-cell malignancies using gemcitabine.

British journal of haematology, 2001, Volume: 113, Issue:1

Topics: Aged; Antimetabolites, Antineoplastic; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Humans; Infusions, Intravenous; Leukemia, Prolymphocytic; Lymphoma, T-Cell; Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Recurrence; Salvage Therapy; Treatment Outcome

2001